Life Vantage Revenue and Competitors
Estimated Revenue & Valuation
- Life Vantage's estimated annual revenue is currently $151.5M per year.
- Life Vantage's estimated revenue per employee is $337,500
Employee Data
- Life Vantage has 449 Employees.
- Life Vantage grew their employee count by -2% last year.
Life Vantage's People
Name | Title | Email/Phone |
---|
Life Vantage Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $354.2M | 937 | 6% | N/A | N/A |
#2 | $4.5M | 24 | -14% | N/A | N/A |
#3 | $25.9M | 96 | -14% | N/A | N/A |
#4 | $18M | 74 | -16% | N/A | N/A |
#5 | $10.8M | 50 | 9% | N/A | N/A |
#6 | $32.9M | 122 | 8% | N/A | N/A |
#7 | $187.3M | 555 | 9% | N/A | N/A |
#8 | $417.7M | 1105 | 22% | N/A | N/A |
#9 | $25.9M | 96 | 28% | N/A | N/A |
#10 | $108.7M | 322 | 8% | N/A | N/A |
What Is Life Vantage?
Direct Sales of the world's only Nrf2 activator supplement.
keywords:N/AN/A
Total Funding
449
Number of Employees
$151.5M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Life Vantage News
2022-04-13 - LifeVantage (NASDAQ:LFVN) Research Coverage Started at ...
LifeVantage (NASDAQ:LFVN) Research Coverage Started at StockNews.com. Posted by admin on Apr 20th, 2022. Share on Twitter Share on Facebook Share on...
2022-04-13 - LifeVantage to Announce Third Quarter Fiscal Year 2022 Results on May 3, 2022 - Benzinga
The Company's line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+...
2022-04-06 - StockNews.com Initiates Coverage on LifeVantage (NASDAQ:LFVN)
The brokerage set a buy rating on the stock. Shares of NASDAQ LFVN opened at $4.59 on Tuesday. LifeVantage has a 12 month low of $4.50 and a...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $84.2M | 449 | 1% | N/A |
#2 | $90.2M | 449 | 1% | N/A |
#3 | $35M | 450 | 8% | N/A |
#4 | $115.3M | 450 | 13% | N/A |
#5 | $163.1M | 450 | 1% | N/A |